Sisram Medical Ltd

Equities

1696

IL0011418113

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
3.12 HKD -3.11% Intraday chart for Sisram Medical Ltd -10.09% -40.68%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sisram Medical’s Profit Down in Fiscal 2023 MT
Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023 CI
Sisram Medical Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sisram Medical Ltd Enters into Strategic Partnership with Prollenium CI
Sisram Medical Ltd Announces the Registration Application of Profhilo CI
Sisram Medical Expects 2023 Revenue To Be Consistent Amid Israel War; Shares Drop 5% MT
Sisram Medical's H1 Profit on Lower Revenue MT
Sisram Medical Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023 CI
Sisram Medical Announces the Launch of Alma Veil for the U.S. Market CI
Sisram Medical Completes Acquisition of Business Related to Alma Lasers MT
PhotonMed HK completed the acquisition of 40% stake in Alma Hong Kong 2023 Limited from Sisram Medical Ltd. CI
FDA Clears Sisram Medical's Adipose Tissue Processing Device for Marketing in the US MT
Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration CI
Chinese Regulator Accepts Sisram Medical’s Drug Registration Application MT
Sisram Medical Ltd Announces Drug Registration Application of Rt002 CI
PhotonMed HK entered into an agreement to acquire 40% stake in Alma Hong Kong 2023 Limited from Sisram Medical Ltd for CNY 270 million. CI
Sisram Medical Ltd Provides Revenue Guidance for the Year 2023 CI
Sisram Medical Ltd Declares a Final Dividend for the Year Ended December 31, 2022 CI
Sisram Medical Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023 CI
Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Chief Financial Officer of the Company with Effect from January 1, 2023 CI
Sisram Medical's H1 Net Profit Rises 25.9% MT
Sisram Medical Ltd Provides Revenue Guidance for the Year 2022 CI
Sisram Medical Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart Sisram Medical Ltd
More charts
Sisram Medical Ltd is an investment holding company principally engaged in the design, development, manufacture and distribution of energy cosmetic medicine and minimally invasive medical cosmetic treatment systems. The Company has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The Company's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The company sells its products in domestic and foreign markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.3983 USD
Average target price
0.7795 USD
Spread / Average Target
+95.71%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1696 Stock
  4. News Sisram Medical Ltd
  5. Sisram Medical to Inject $5.5 Million into Fuzhou Rick Brown Bio-technology; Shares Surge 23%